Zentalis to Cut 40% of Workforce Under Strategic Restructuring Plan
The reduction is expected to be “substantially completed,” the San Diego-based company said, in the second quarter of 2025.
Drug Solutions Podcast: Realizing AI’s Potential
This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.
European Drug Shortage Monitoring Platform Fully Operational
The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.
Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends
In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.
European Commission Approves Johnson & Johnson Non-Small Cell Lung Cancer Treatment
Data from a Phase III study that evaluated lazertinib, in combination with amivantamab, in comparison to osimertinib as a first-line treatment resulted in the EC’s decision.
AstraZeneca Makes Investment to Create 700 High-Skilled Jobs in Greater Toronto Area
The company’s investments in Canada since 2023 have now resulted in the creation, or potential thereof, of 1200 new job positions.
